Latest Methicillin-resistant Staphylococcus aureus Stories

Research Offers New Clues To Prevent Infection In Cardiac Devices

2012-04-10 12:48:04

Bacteria such as Staphylococcus aureus, the ‘superbug’ behind MRSA, can be a major problem for patients who have a medical implant, such as a replacement heart valve or pacemaker. Bacteria are able to form colonies -- called biofilms -- on the implanted device, which can lead to wider infections such as endocarditis, a bacterial infection of the heart. Research led by scientists in the Department of Biology at the University of York has shed new light on how these “biofilm”...

Live Experiment Shows That MRSA Dies on Antimicrobial Copper Surfaces

2012-04-10 06:28:38

NEW YORK, April 10, 2012 /PRNewswire/ -- MRSA--the super virulent bacteria that is a leading cause of infections during patient hospitalization--has met its match: Antimicrobial Copper. A live webcast experiment (http://www.antimicrobialtouchsurface.com/) demonstrated that Antimicrobial Copper effectively kills MRSA within two hours while it readily survives on stainless steel. "Antimicrobial copper is part of the solution in the fight against healthcare-acquired infections - it...

Fight MRSA - International MRSA Testing Week, April 1-7th

2012-04-02 02:28:43

CHICAGO, April 2, 2012 /PRNewswire-USNewswire/ -- MRSA, the antibiotic resistant staph bacteria that has been a secret and silent killer in healthcare facilities for decades is at epidemic levels worldwide. MRSA Survivors Network, a global leader in the fight for MRSA awareness, education and prevention launches this week - "International MRSA Testing Week, April 1-7th" a new global campaign with the slogan "Prevention Saves Lives" that draws critical attention for the need of...

Molecular Detection Inc. Launches Improved Version of Detect-Ready® MRSA Panel at 2012 ECCMID Congress

2012-03-30 02:23:23

LONDON and WAYNE, Pa., March 30, 2012 /PRNewswire/ -- Molecular Detection Inc. (MDI), a company developing Detect-Ready® tests designed to increase the speed and accuracy of infectious disease diagnosis, today announced it will release a new version of its Detect-Ready MRSA Panel at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). The superior performance of the Detect-Ready MRSA Panel has been further enhanced by increasing the number of...

Tiny Sensors Could Aid Rapid MRSA Detection

2012-03-29 22:00:30

A simple test to identify MRSA in wounds could identify the superbug quickly and help prevent infection from spreading. Scientists have developed the test to show whether wounds or lesions are infected with bacteria and if MRSA is present. Test The test, developed at the University of Edinburgh in collaboration with NHS Lothian, works by taking swabs from a wound or sores. These are then analyzed using a strip with electrical sensors that can detect MRSA. Researchers currently...

Infection Prevention Groups Outline Steps Needed To Preserve Antibiotics

2012-03-19 16:11:41

APIC, SHEA issue position paper on role of infection preventionists and health care epidemiologists in antimicrobial stewardship Infection preventionists and healthcare epidemiologists play key roles in promoting effective antimicrobial stewardship in collaboration with other health professionals, according to a joint position paper published today by the Association for Professionals in Infection Control and Epidemiology (APIC) and the Society for Healthcare Epidemiology of America (SHEA)...

Foamix's Minocycline Foam - 100% Effective in Impetigo Phase II Clinical Trial With No Side Effects - 80% Improved Significantly After 3 Days of Treatment

2012-03-14 13:20:00

REHOVOT, Israel, March 14, 2012 /PRNewswire/ -- Foamix, a clinical stage specialty pharmaceutical company, announced today the successful completion of the Phase II clinical trial of Minocycline foam in Impetigo patients. Minocycline Foam has shown to be highly effective against bacteria, including some multi-drug resistant strains (such as MRSA). The randomized double blind Phase II clinical study, conducted in pediatric patients with impetigo, was designed to assess...

Bend Research Technology Helps Advance Promising Compound

2012-03-13 05:00:00

BEND, Ore., March 13, 2012 /PRNewswire/ -- Bend Research Inc. (www.bendresearch.com), a leading independent drug-formulation development and manufacturing company, today announced a licensing agreement with Affinium Pharmaceuticals, Ltd. (www.afnm.com). Bend Research has licensed its proprietary spray-dried dispersion (SDD) technology to the biotechnology firm. The SDD technology, which is used to improve the bioavailability of compounds with low aqueous solubility, has been...

Collaboration Needed To Facilitate Rapid Response To Health-Care-Associated Infections

2012-03-08 15:46:22

The U.S. Department of Health and Human Services (HHS) estimates that about one in every 20 patients develops an infection each year related to their hospital care. The key to preventing an outbreak of potentially deadly healthcare-associated infections (HAIs) -- such as methicillin-resistant Staphylococcus aureus (MRSA) or C. difficile -- is identifying them before affected individuals can pose a transmission risk. But, according to a survey released today by the Association for...

Molecular Detection Inc. Completes $1.5 Million Financing to Advance New Tests for Sepsis and GI Disorders

2012-03-07 06:30:00

WAYNE, Pa., March 7, 2012 /PRNewswire/ -- Molecular Detection Inc. (MDI), a company developing Detect-Ready® tests designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has completed a $1.5 million financing. The funds are primarily being used to advance MDI's new molecular diagnostic panels for the detection of sepsis and gastrointestinal (GI) diseases. Separately, MDI announced allowance of a new European patent for its...